Myocardial perfusion quantification in patients suspected of cardiac syndrome X with positive and negative exercise testing: A [N]ammonia positron emission tomography study

Nuclear Medicine Communications

Volumn 27, Issue 10, 2006, Pages 791-794

  de Vries, Jessica ^a   DeJongste, Mike J L ^a   Jessurun, Gillian A J ^a   Jager, Pieter L ^b   Staal, Michiel J ^b   Slart, Riemer H J A ^b  

^a Faculty of Medicine   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Cardiac syndrome X; Exercise testing; Positron emission tomography

Indexed keywords

AMMONIA N 13; DIPYRIDAMOLE;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; CARDIAC PATIENT; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; EXERCISE TEST; FEMALE; HEART MUSCLE PERFUSION; HUMAN; MALE; OUTCOME ASSESSMENT; POSITRON EMISSION TOMOGRAPHY; QUANTITATIVE ANALYSIS; ST SEGMENT; STATISTICAL SIGNIFICANCE; SYNDROME X; THORAX PAIN;

ADULT; AMMONIA; DIAGNOSTIC IMAGING; DIPYRIDAMOLE; EXERCISE TEST; FEMALE; HUMANS; MALE; MICROVASCULAR ANGINA; MIDDLE AGED; NITROGEN RADIOISOTOPES; PERFUSION; POSITRON-EMISSION TOMOGRAPHY;

EID: 33748755720     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/01.mnm.0000237984.46844.42     Document Type: Article

References (22)

1. Kemp HG, Kronmal RA, Vlietstra RE, Frye RL. Seven year survival of patients with normal or near normal coronary arteriograms: a CASS registry study. J Am Coll Cardiol 1986; 7:479-483.
2. Kemp HG Jr. Left ventricular function in patients with the anginal syndrome and normal coronary arteriograms. Am J Cardiol 1973; 32:375-376.
3. Kaski JC, Crea F, Nihoyannopoulos P, Hackett D, Maseri A. Transient myocardial ischemia during daily life in patients with syndrome X. Am J Cardiol 1986; 58:1242-1247.
4. Cannon RO III, Camici PG, Epstein SE. Pathophysiological dilemma of syndrome X. Circulation 1992; 85:883-892.
5. Cannon RO III, Epstein SE. ‘Microvascular angina’ as a cause of chest pain with angiographically normal coronary arteries. Am J Cardiol 1988; 61:1338-1343.
6. Diamond GA. A clinically relevant classification of chest discomfort. J Am Coll Cardiol 1983; 1:574-575.
7. Weber KT, Janicki JS. Equipment and protocols to evaluate the exercise response. In: Weber KT, Janicki JS (editors): Cardiopulmonary exercise testing. Physiologic principles and clinical applications. Philadelphia: WB Saunders Company; 1986, pp. 138-150.
8. Schelbert HR, Phelps ME, Huang SC, MacDonald NS, Hansen H, Selin C, et al. N-13 ammonia as an indicator of myocardial blood flow. Circulation 1981; 63:1259-1272.
9. Blanksma PK, Willemsen AT, Meeder JG, de Jong RM, Anthonio RL, Pruim J, et al. Quantitative myocardial mapping of perfusion and metabolism using parametric polar map displays in cardiac PET. J Nucl Med 1995; 36:153-158.
10. Cannon RO III. Association of abnormal left-ventricular reponse to exercise with dynamic limitation in coronary flow reserve in patients with chest pain, angiographically normal coronary-arteries. Circulation 1992; 86:588.
11. Taggart P, Sutton P, Opthof T, Coronel R, Kallis P. Electrotonic cancellation of transmural electrical gradients in the left ventricle in man. Prog Biophys Mol Biol 2003; 82:243-254.
12. Tousoulis D, Crake T, Lefroy DC, Galassi AR, Maseri A. Left-ventricular hypercontractility and ST segment depression in patients with syndrome-X. J Am Coll Cardiol 1993; 22:1607-1613.
13. Holdright DR, Lindsay DC, Clarke D, Fox K, Poole Wilson PA, Collins P. Coronary flow reserve in patients with chest pain and normal coronary arteries [Abstract]. Br Heart J 1993; 70:513-519.
14. Mosseri M, Yarom R, Gotsman MS, Hasin Y. Histologic evidence for small-vessel coronary-artery disease in patients with angina-pectoris and patent large coronary-arteries. Circulation 1986; 74:964-972.
15. Kaski JC, Aldama G, Cosin-Sales J. Cardiac syndrome X. Diagnosis, pathogenesis and management. Am J Cardiovasc Drugs 2004; 4:179-194.
16. Jessurun GA, Hautvast RW, Tio RA, DeJongste MJ. Electrical neuromodulation improves myocardial perfusion and ameliorates refractory angina pectoris in patients with syndrome X: fad or future? Eur J Pain 2003; 7:507-512.
17. Lanza GA, Sestito A, Sgueglia GA, Infusino F, Papacci F, Visocchi M, et al. Effect of spinal cord stimulation on spontaneous and stress-induced angina and ‘ischemia-like’ ST-segment depression in patients with cardiac syndrome X. Eur Heart J 2005; 26:983-989.
18. 123I-metaiodobenzylguanidine scintigraphic uptake and heart rate variability in patients with syndrome X. Ital Heart J 2000; 1:221-225.
19. Camici PG, Marraccini P, Gistri R, Salvadori PA, Sorace O, Labbate A. Adrenergically mediated coronary vasoconstriction in patients with syndrome-X. Cardiovasc Drugs Ther 1994; 8:221-226.
20. Montorsi P, Fabbiocchi F, Loaldi A, Annoni L, Polese A, De Cesare N, et al. Coronary adrenergic hyperreactivity in patients with syndrome X and abnormal electrocardiogram at rest. Am J Cardiol 1991; 68:1698-1703.
21. Rosano GMC, Ponikowski P, Adamopoulos S, Collins P, Poole-Wilson PA, Coats AJS, et al. Abnormal autonomic control of the cardiovascular-system in syndrome-X. Am J Cardiol 1994; 73:1174-1179.
22. Knuuti J, Sipola P. Is it time for cardiac innervation imaging? Q J Nucl Med Mol Imaging 2005; 49:97-105.